Gregoire Rondelet

Gregoire Rondelet is a researcher specializing in epigenetic cancer therapy, with a focus on DNA methyltransferases and their inhibition. He has collaborated extensively with J. Wouters and other colleagues on structural studies and drug development projects.

• Key affiliations include University of Liège (inferred from context)
• Active in structural biology, enzymology, and medicinal chemistry

His research explores the molecular mechanisms of DNA methylation, histone interactions, and the design of non-nucleoside inhibitors for cancer treatment. Publications highlight collaborations with European institutions and contributions to structural biology databases.

Scientific contributions include:

• Best Communication Prize at Séminaire des chercheurs Télévie (2015)
• Targeting DNA methylation for ATLL therapy (2015)

His work spans high-impact areas such as cancer epigenetics, enzyme inhibition, and structure-based drug design, with research outputs cited over 197 times (h-index: 4). Activities include participation in international conferences and advanced training programs like the Vienna Summer School.